IJR News - today's news from every side

IJR News - today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Genius — OpenServe

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

OpenServe Drive OpenServe Inbox OpenServe Write OpenServe Studio OpenServe Projects OpenServe Focus OpenServe Mindmaps Teams OpenServe CRM Site Builder Whiteboard

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Popular
Congress

Genius — OpenServe

Hot Wheels Releases, Costco Gear, Santa Cruz Show AheadAuto — 5dHot Wheels previews point to a slate of 2026–27 collectibles, including a holiday Volkswagen T1 Rockster, a Ferrari 312 P, new Pantone-series models and other RLC and Walmart-exclusive releases. Collectors are advised to buy what they enjoy and be patient for standard RLC models, while convention exclusives and limited-run cars can be harder to find and more expensive; an upcoming Mexico convention will feature a Mariachi-themed Chevrolet C10.

0

Opus Genetics completes dosing in higher-dose retinal gene therapy cohortHealth — 6dOpus Genetics completed dosing all 11 participants in the higher-dose cohort of its Phase 1/2 trial of OPGx-BEST1 for inherited retinal diseases. The company expects three-month results in early 2027; encouraging improvements reported in the earlier, five-person cohort are preliminary and do not establish how the higher dose will perform.

0

Meme claims Trump Mobile took $59 million in T1 phone deposits — Sep 20, 2026Meme Wars: trending on the Left today.

0

Microchip 10BASE T1STech — Sep 29, 2026

0

IJRBlue State Residents Balk At NFL Owner’s $16 Billion Data Center Project That Could Cut Their Property TaxesSimon August · 6 min · 10h

Swiss Groups Pressure Parliament Over UBS Capital Rules — Sep 21, 2026With Parliament set to vote on tightened capital rules after the Credit Suisse collapse, UBS warns that 100% CET1 backing would erode competitiveness and cost billions, while backing a compromise—potentially 50% CET1 with AT1 or similar arrangements—to cushion the impact. Industry groups press lawmakers to avoid overly harsh rules, arguing higher capital costs would raise financing costs for Swiss companies and hurt the financial center, as UBS and lawmakers weigh a viable middle ground that could require roughly $13–20 billion in additional capital.

+1

Jared Kim Lawmakers should accept the compromise on capital rules so Swiss firms don't face much higher borrowing costs.

Most Influential Women in World HistoryYourlist — RankingFrom ancient queens who ruled empires to modern activists who changed laws, these women left indelible marks on politics, science, and culture. Vote for who you think shaped history most profoundly.

Canadian banks cite AI push and stronger equity returns at summit — Sep 9, 2026Scotiabank executives outlined a modernization and efficiency push driven by organic growth and technology, aiming to lift ROE across Canadian and U.S. franchises while maintaining strong capital and risk discipline. They cited solid CET1 buffers, rising ROE across units, expanded U.S. presence and wealth growth plans, and AI-enabled initiatives and selective tuck-in acquisitions to support a higher earnings trajectory.

+2

Elena Vasquez Scotiabank's plan to use AI for efficiency while holding solid capital looks practical for lifting ROE in both countries.

Bankinter Q2 profit beats estimates on lending feesFinance — Jul 23, 2026Bankinter's Q2 net profit rose about 16% year-on-year to €315 million driven by higher lending income and a 23% jump in fees, with net interest income up around 5% as rates and funding costs influence margins. The results, accompanied by strong half-year metrics such as ROE around 19%, NPL near 1.92%, and a CET1 ratio about 12.9%, reinforce a diversified, still-expanding business despite the rate environment.

0

Flagstar Q2 Earnings Miss, Revenue Misses Forecast — Jul 22, 2026Flagstar Bank’s Q2 2026 results show non-GAAP EPS of $0.05, missing consensus by $0.02, and revenue of $516 million, below expectations by about $25 million, though the bank remains profitable for a third straight quarter with 4% year-over-year revenue growth. The report also notes a CET1 capital ratio around 13.16% and a tangible book value per share of roughly $17.51 as investors weigh balance-sheet improvements and valuation.

0

US tariffs Singapore; Allianz buys HSBC Singapore insurer — Jul 23, 2026The US has imposed a 12.5% tariff on Singapore over forced-labor concerns, while Allianz agreed to buy HSBC’s Singapore Life unit for about US$2.9 billion, reflecting a broader push to streamline portfolios in Singapore. HSBC’s sale, including a 15-year exclusive bancassurance distribution deal, is part of its strategy to free capital and focus on core markets, potentially boosting CET1 and enabling higher returns.

0

FaithTapIreland Crowd Hurls Insults, Object at BidenFormer President Joe Biden did not receive a warm reception Tuesday during his visit to Ireland alongside former first lady Jill Biden. A crowd of anti-Israel agitators hurled ins… — by Sandra Rhodes9h · 11 reads

John Marshall Bancorp posts Q2 2026 earnings beat — Jul 22, 2026Banks reported solid quarterly results across the board: John Marshall Bancorp beat earnings expectations with a $0.50 EPS and $18.83 million revenue, marking the eighth straight quarter of net income growth, while Mid Penn Bancorp posted strong June-quarter earnings and declared a quarterly dividend. Jamuna Bank also logged a 22% H1 profit rise to Tk378.29 crore on investment income gains and lower loan provisions, and JMSB highlighted a stronger balance sheet with book value per share at $19.40, a CET1 ratio of 15.6%, and over $2 billion in loans as it continues growth.

0

Crystalys Therapeutics raises $130M Series B — Jul 22, 2026Crystalys Therapeutics has raised a $130 million Series B led by Frazier Life Sciences with participation from multiple investors to fund late-stage global trials and commercialization plans for dotinurad, its URAT1 inhibitor for gout. The financing backs the RUBY, TOPAZ, and AMETHYST studies and aims to accelerate regulatory milestones and commercial readiness across the U.S. and Europe as the company positions dotinurad as a best-in-class option between first-line therapies and last-line treatments.

0

New York Pizza vs Chicago Deep DishYourlist — VS BattleThe foldable slice versus the fork-and-knife casserole — America's longest-running food fight.

Liz Cheney Swift to Point Out Sold Out Concert to Trump — Jun 24, 2024Former Rep. Liz Cheney (R-Wyo.) was swift in making fun of former President Donald Trump by pointing out the size of the audience at a recent Taylor Swift concert. “Thank you @taylorswift13 for giving us a million…

0